MENU
MDGL
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Madrigal Pharmaceuticals (MDGL) Earnings Date & Reports

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality... Show more

A.I. Advisor
published Earnings

MDGL is expected to report earnings to rise 5.12% to -349 cents per share on August 06

Madrigal Pharmaceuticals MDGL Stock Earnings Reports
Q2'25
Est.
$-3.49
Q1'25
Beat
by $0.54
Q4'24
Beat
by $1.77
Q3'24
Beat
by $1.84
Q2'24
Beat
by $0.38
The last earnings report on May 01 showed earnings per share of -331 cents, beating the estimate of -385 cents. With 292.45K shares outstanding, the current market capitalization sits at 6.09B.
View a ticker or compare two or three
MDGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of small-molecule drugs addressing major unmet needs in cardiovascular and metabolic diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
200 Barr Harbor Drive
Phone
+1 267 824-2827
Employees
276
Web
http://www.madrigalpharma.com